Literature DB >> 17610532

The safety of kava: a regulatory perspective.

W N Richardson1, L Henderson.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17610532      PMCID: PMC2048547          DOI: 10.1111/j.1365-2125.2007.02933.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  2 in total

Review 1.  Adverse effects of St. John's Wort: a systematic review.

Authors:  Lars Knüppel; Klaus Linde
Journal:  J Clin Psychiatry       Date:  2004-11       Impact factor: 4.384

Review 2.  Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.

Authors:  Jean-Pierre Cosyns
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

  2 in total
  2 in total

1.  Kava, the anxiolytic herb: back to basics to prevent liver injury?

Authors:  Rolf Teschke; Jerome Sarris; Xaver Glass; Johannes Schulze
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

2.  Kava hepatotoxicity in traditional and modern use: the presumed Pacific kava paradox hypothesis revisited.

Authors:  Rolf Teschke; Jerome Sarris; Isaac Schweitzer
Journal:  Br J Clin Pharmacol       Date:  2012-02       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.